New directions in poly(ADP-ribose) polymerase biology

被引:61
|
作者
Bock, Florian J. [1 ,2 ]
Chang, Paul [3 ]
机构
[1] Canc Res UK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Canc Sci, Garscube Estate, Glasgow, Lanark, Scotland
[3] Ribon Therapeut, Lexington, MA 02421 USA
关键词
ADP-ribosylation; poly(ADP-ribose) polymerases; post-translational modification; stress response; NF-KAPPA-B; ADP-RIBOSYLTRANSFERASE ARTD10; PROTEOME-WIDE IDENTIFICATION; DNA STRAND BREAKS; RNA REGULATION; STRESS RESPONSES; MAMMALIAN-CELLS; ES CELLS; T-CELLS; RIBOSE;
D O I
10.1111/febs.13737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerases (PARPs) regulate the function of target proteins by modifying them with ADP-ribose, a large and unique post-translational modification. Humans express 17 PARPs; however, historically, much of the focus has been on PARP1 and its function in DNA damage repair. Recent work has uncovered an amazing diversity of function for these enzymes including the regulation of fundamental physiological processes in the cell and at the organismal level, as well as new roles in regulating cellular stress responses. In this review, we discuss recent advancements in our understanding of this important protein family, and technological developments that have been critical for moving the field forward. Finally, we discuss new directions that we feel are important areas of further scientific exploration.
引用
收藏
页码:4017 / 4031
页数:15
相关论文
共 50 条
  • [31] Poly (ADP-ribose) polymerase and brain ischemia
    Traystman, RJ
    Kofler, J
    Sawada, M
    Martin, LJ
    Dawson, VL
    Hurn, PD
    MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 : 21 - 29
  • [32] Poly (ADP-ribose) polymerase: a survival factor
    Pozo, FJO
    de Brito Sanchez, MG
    Niedergang, C
    Menissier-de Murcia, J
    de Murcia, G
    M S-MEDECINE SCIENCES, 1998, 14 (11): : 1196 - 1203
  • [33] Regulatory mechanisms of poly(ADP-ribose) polymerase
    Rafael Alvarez-Gonzalez
    Trent A. Watkins
    Paramjit K. Gill
    Jason L. Reed
    Hilda Mendoza-Alvarez
    Molecular and Cellular Biochemistry, 1999, 193 : 19 - 22
  • [34] Proteomic Investigation of Phosphorylation Sites in Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase
    Gagne, Jean-Philippe
    Moreel, Xavier
    Gagne, Pierre
    Labelle, Yves
    Droit, Arnaud
    Chevalier-Pare, Melissa
    Bourassa, Sylvie
    McDonald, Darin
    Hendzel, Michael J.
    Prigent, Claude
    Poirier, Guy G.
    JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) : 1014 - 1029
  • [35] Increased Brain Poly (ADP-Ribose) after Ischemic Stroke Are Attenuated by Poly (ADP-Ribose) Polymerase Inhibitor
    Kim, Y. S.
    Kim, H. Y.
    Yoo, A.
    Noh, M. Y.
    Kim, S. H.
    CEREBROVASCULAR DISEASES, 2016, 42 : 89 - 89
  • [36] CYTOPLASMIC POLY(ADP-RIBOSE) POLYMERASE AND POLY(ADP-RIBOSE) GLYCOHYDROLASE IN AEV-TRANSFORMED CHICKEN ERYTHROBLASTS
    THOMASSIN, H
    DESA, CM
    SCHERRER, K
    MANIEZ, C
    MANDEL, P
    MOLECULAR BIOLOGY REPORTS, 1988, 13 (01) : 35 - 44
  • [37] A human poly(ADP-ribose) polymerase gene family (ADPRTL):: cDNA cloning of two novel poly(ADP-ribose) polymerase homologues
    Johansson, M
    GENOMICS, 1999, 57 (03) : 442 - 445
  • [38] Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach
    Zaffini, Raffaela
    Gotte, Giovanni
    Menegazzi, Marta
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 281 - 293
  • [39] The clinical development of inhibitors of poly(ADP-ribose) polymerase
    Calvert, H.
    Azzariti, A.
    ANNALS OF ONCOLOGY, 2011, 22 : i53 - i59
  • [40] Cardioprotective effects of poly (ADP-ribose) polymerase inhibition
    Szabó, C
    PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 34 - 43